$KNW News

Last published 1y ago

1y agoKNW USBCCORRECTION: Greg Kidd & Know Labs Announce Closing of $125M Strategic AcquisitionACCESS NewswireContribution of 1,000 Bitcoin to employ yield generation treasury strategyCorporate name and ticker symbol will change
1y agoKNW USBCGreg Kidd & Know Labs Announce Closing of [$100]M Strategic AcquisitionACCESS NewswireContribution of 1,000 Bitcoin to employ yield generation treasury strategyCorporate name and ticker symbol will change to USBCGreg Kidd to lead USBC as Chairman and CEO; USBC token sets new vision CRYSTAL BAY, NV AND
1y agoKNWKnow Labs, Inc. Announces Adjournment of Special Meeting of StockholdersBusiness WireKnow Labs, Inc. (NYSE American: KNW ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today announced that it has adjourned its Special Meeting of
1y agoKNWKnow Labs Reminds its Stockholders to Vote Ahead of the Special Meeting on July 24Business WireKnow Labs, Inc. (NYSE:KNW) ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today issued a reminder to its stockholders to vote ahead of the Special
1y agoKNWGreg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury StrategyBusiness WireKnow Labs, Inc. (NYSE American: KNW ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today announced that it has entered into an agreement with Goldeneye
1y agoKNWKnow Labs Sensor Non-Invasively Identifies pH Levels in Real TimeBusiness WireSignificant Applications in Health Care, Food Quality and Safety and More Know Labs, Inc. (NYSE:KNW) is pleased to announce that it has completed extensive research in its laboratory utilizing its patented Radio
1y agoKNWKnow Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)Business WireThe company to meet with potential strategic partners to discuss collaborating on advancing clinical research of its non-invasive blood glucose monitor Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive
1y agoKNW KNWNKnow Labs Files Appeal to NYSE Commencement of Proceedings to DelistBusiness WireKnow Labs Continues Trading as "KNWN" on the OTC Market Know Labs, Inc. (NYSE:KNW, now OTC Markets: KNWN)), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS),
1y agoKNW KNWNKnow Labs Responds to NYSE Commencement of Proceedings to DelistBusiness WireKnow Labs Trading as "KNWN" on the OTC Market Know Labs, Inc. (NYSE:KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today it is working on
1y agoKNWKnow Labs Launches Know Labs Technology Licensing (KTL)Business WireCompany to Drive Monetization of its Patented Platform Technology Across Diverse Industries Know Labs, Inc. (NYSE:KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy
1y agoKNWKnow Labs, Inc. Announces $300K Registered Direct OfferingBusiness WireKnow Labs, Inc. (NYSE:KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a registered direct offering with gross proceeds to the company of
1y agoKNWKnow Labs, Inc. Announces NYSE American Acceptance of Plan to Regain ComplianceBusiness WireKnow Labs, Inc. (NYSE:KNW), leading developer of non-invasive diagnostics technology, today announced that on December 10, 2024, it received notification (the "Acceptance Letter") from the NYSE American LLC (the
1y agoKNWKnow Labs Provides Overview of FY2024 10-K Annual ReportBusiness WireThe Company Responds to Shareholder Concerns and Reiterates Progress and Future Plans Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its
1y agoKNWKnow Labs, Inc. Announces Receipt of Audit Opinion with Going Concern ExplanationBusiness WireKnow Labs, Inc. (NYSE:KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended September 30, 2024, which was
1y agoKNWKnow Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 ResultsBusiness WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal year ended September 30, 2024. Financial
2y agoKNWKnow Labs Announces Expanded Technology Leadership in its Executive TeamBusiness WireAcceleration of Platform Development to Secure Multiple Strategic Partnerships Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive diagnostics technology, announced today two additions to its executive
2y agoKNWKnow Labs Sensor Technology in Steering Wheels Could Curb Impaired DrivingBusiness WireKnow Labs Retains the Stanbridge Group to Secure Automotive Joint Venture Partnerships Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive sensor technology, announced today that it has retained The
2y agoKNWKnow Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsBusiness WireA Plan for Compliance and Activities to Increase Know Labs Valuation have been Undertaken Know Labs, Inc. (NYSE:KNW) (the "Company" or "Know Labs"), a leading developer of non-invasive diagnostics technology, announced
2y agoKNWKnow Labs Study Published in IEEE Sensors JournalBusiness WirePeer-reviewed journal publication validates the novelty of Know Labs' proprietary radiofrequency (RF) dielectric sensor and its application for non-invasive blood glucose monitoring Know Labs, Inc. (NYSE:KNW), a
2y agoKNWKnow Labs, Inc. Announces $1.655 Million Public OfferingBusiness WireKnow Labs, Inc. (NYSE:KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced that it has entered into definitive agreements with certain investors to purchase 6,365,385
2y agoKNWKnow Labs, Inc. (KNW) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoKNWKnow Labs, Inc. Reports Third Quarter FY 2024 ResultsBusiness WireKnow Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter of the fiscal year 2024 ended June 30, 2024. Financial
2y agoKNWKnow Labs, Inc. Announces Closing of $3.445 Million Public OfferingBusiness WireKnow Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostics technology, today announced the successful closing of its previously announced underwritten public offering of 13,250,000 units at a
2y agoKNWKnow Labs, Inc. Announces Pricing of $3.445 Million Public OfferingBusiness WireKnow Labs, Inc. (NYSE:KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment underwritten public offering of 13,250,000 units at a
2y agoKNWKnow Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024Business WireKnow Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its third quarter of the fiscal year 2024
2y agoKNWKnow Labs Publishes Clinical Results in Leading Diabetes JournalBusiness WireStudy demonstrates accuracy for a proof-of–concept non-invasive glycemic status screening device. Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today announced the
2y agoKNWKnow Labs to Present at the American Diabetes Association's Scientific SessionsBusiness WireLatest clinical research results demonstrate a stable MARD in an expanded dataset. Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today announced further interim results
2y agoKNWKnow Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard UniversityBusiness WireThe Company's experience in developing novel, next generation medical diagnostic technology aligns with the Wyss Diagnostics Accelerator's mission of delivering disruptive innovation to address unmet clinical
2y agoKNWKnow Labs Appoints Chris Somogyi as President, InternationalBusiness WireSomogyi to lead Know Labs' "Skunkworks" Program and drive global revenues. Know Labs, Inc. (NYSE:KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi
2y agoKNWKnow Labs, Inc. (KNW) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoKNWKnow Labs, Inc. Reports Second Quarter FY 2024 ResultsBusiness WireKnow Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal year 2024 ended March 31, 2024. Financial
2y agoKNWKnow Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual MeetingBusiness WireThe Company's oral abstract presentation features results from its clinical study that demonstrate the accuracy and medical application of its proprietary sensor. Know Labs, Inc. (NYSE:KNW), an emerging developer of
2y agoKNWKnow Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024Business WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its second quarter of the fiscal year
2y agoKNWKnow Labs to Present Clinical Research at the 2024 American Physiology SummitBusiness WireThe Company demonstrates significant progress since presenting at last year's Summit. Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been
2y agoKNWKnow Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyBusiness WireKnow Labs' first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor's accuracy and medical application. Know Labs, Inc. (NYSE:KNW), an emerging
2y agoKNWKnow Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development InitiativesBusiness WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has entered into a funding agreement for an investment of up to $12 million, of which it has executed a
2y agoKNWKnow Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose MonitorBusiness WireThe KnowU incorporates the sensor intended for FDA submission Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the KnowU™, its wearable
2y agoKNWKnow Labs, Inc. (KNW) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoKNWKnow Labs, Inc. Reports First Quarter FY2024 ResultsBusiness WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the first quarter ended December 31, 2023. Financial Highlights: In Q1 FY 2024,
2y agoKNWKnow Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024Business WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its first quarter of the fiscal year
2y agoKNWKnow Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)Business WireThe Company to present updated clinical research results and developments of its non-invasive blood glucose monitor Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology,
2y agoKNWKnow Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 ResultsBusiness WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal year ended September 30, 2023. Financial
2y agoKNWKnow Labs Expands Medical and Scientific Advisory BoardBusiness WireNew Members Bring Extensive Clinical Diabetes Management and FDA Expertise Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of four new
2y agoKNWKnow Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023Business WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its fiscal year ended on September 30,
3y agoKNWKnow Labs Expands Board of DirectorsBusiness WireAppoints Three New Directors with Deep Sector Expertise Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of three new members to the
3y agoKNWKnow Labs Presents at Third Annual Bernstein CGM Disruptors Conference, Details Significant Progress During the Past YearBusiness WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, will present at the third annual Bernstein CGM Disruptors Conference on Thursday, November 2, 2023. Presenters and
3y agoKNWKnow Labs, Inc. Announces Pricing of $7 Million Public Offering of Common StockBusiness WireKnow Labs, Inc. (NYSE:KNW) (the "Company"), an emerging developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment underwritten public offering of 28,000,000 shares of its
3y agoKNWKnow Labs, Inc. Reports Third Quarter FY2023 ResultsBusiness WireKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter ended June 30, 2023. Financial Highlights: Know Labs reported
3y agoKNWKnow Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose MonitoringBusiness WireThe company's Bio-RFID™ technology takes shape as a powerful, research-grade device Know Labs (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, revealed the next stage in the
3y agoKNWKnow Labs' Non-Invasive Glucose Monitoring Technology Shows Improved AccuracyBusiness WireLatest study demonstrates a machine learning model improved Bio-RFID™ sensor's accuracy for predicting blood glucose, using the Dexcom G6® as reference device Know Labs, Inc. (NYSE:KNW) today announced the